Pediatric Intravenous Iron Therapy: Evaluating the Safety and Efficacy of Iron Isomaltoside and Low‐Molecular‐Weight Dextran
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.32093 ↗At a glance
Journal article in Pediatric Blood & Cancer, 2025. Written by Ernesta Dragūnė and 4 co-authors. Institution: Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Major MEDLINE topics: Anemia, Iron-Deficiency, Disaccharides, Ferric Compounds. Cited 1 times so far (Crossref); 30 references.
Abstract (original language)
Background Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent among children and adolescents, affecting growth and development. Although oral iron is the first‐line treatment, intravenous (IV) iron is required in cases of poor tolerance or inadequate response. While some IV formulations are used in pediatric clinical practice, no published data on the safety and efficacy of iron isomaltoside (IIM) in the pediatric population exist, while data on low‐molecular‐weight dextran (LMWD) remain limited. Procedure Our retrospective cohort study at Vilnius University Hospital Santaros Klinikos (2021–2023) included pediatric patients (
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- Institute of Data Science and Digital Technologies, Faculty of Mathematics and Informatics, Vilnius University, Vilnius, Lithuania.
- Clinic of Children's Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
ORCID profiles: Sonata Šaulytė Trakymienė
Cite
APA
Dragūnė, E., Morkūnaitė, A., Trakymas, G. B., Vaišnorė, R., & Šaulytė Trakymienė, S. (2025). Pediatric Intravenous Iron Therapy: Evaluating the Safety and Efficacy of Iron Isomaltoside and Low‐Molecular‐Weight Dextran. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32093
Vancouver
Dragūnė E, Morkūnaitė A, Trakymas GB, Vaišnorė R, Šaulytė Trakymienė S. Pediatric Intravenous Iron Therapy: Evaluating the Safety and Efficacy of Iron Isomaltoside and Low‐Molecular‐Weight Dextran. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.32093
BibTeX
@article{Dragn2025,
author = {Dragūnė, Ernesta and Morkūnaitė, Agnė and Trakymas, Gaudas Benediktas and Vaišnorė, Ramunė and Šaulytė Trakymienė, Sonata},
title = {Pediatric Intravenous Iron Therapy: Evaluating the Safety and Efficacy of Iron Isomaltoside and Low‐Molecular‐Weight Dextran},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.32093}
}
EUVIMED